Pharmacokinetic (PK) interaction between epidoxorubicin (EPI) and docetaxel (TXT) in patients with metastatic breast cancer (MBC)

被引：1
|
作者：
Cattel, L
Airoldi, M
Brusa, P
Tagini, V
Recalenda, V
Marchionatti, S
Bumma, C
Pedani, F
机构：
[1] Univ Hosp Pharmacol, Turin, Italy
[2] Dept Oncol, Turin, Italy
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
10.1016/S0959-8049(99)81734-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1318
引用
收藏
页码：S328 / S328
页数：1
相关论文
共 50 条
  • [1] Pharmacokinetic (PK) interaction between doxorubicin (DOX) and docetaxel (TXT) in patients with advanced cancer: DOX dose-dependent interaction.
    Baker, SD
    Kennedy, MJ
    Bruno, R
    Smetzer, L
    Kiraly, S
    Grochow, LB
    Rowinsky, EK
    CLINICAL CANCER RESEARCH, 2000, 6 : 4535S - 4535S
  • [2] Preliminary efficacy and tolerance results of docetaxel (taxotere) (TXT) in heavily pretreated metastatic breast cancer patients (MBC)
    Chahine, A
    Trandafir, L
    Errihani, H
    DesGuetz, G
    Musset, M
    Jasmin, C
    Cvitkovic, E
    Misset, JL
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 382 - 382
  • [3] Pharmacokinetic (PK) characterization of irinotecan liposome injection in patients (pts) with metastatic breast cancer (mBC).
    Anders, Carey K.
    Sachdev, Jasgit C.
    Munster, Pamela N.
    Pedret-Dunn, Anna
    Maxwell, Fiona
    Northfelt, Donald W.
    Han, Hyo S.
    Ma, Cynthia X.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [4] Single-agent docetaxel (TXT) as first-line treatment in metastatic breast cancer (MBC)
    Guarneri, D.
    Ratti, R.
    Venturino, A.
    Addamo, G.
    Coccorullo, Z.
    Colloca, G.
    Campora, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [5] TREATMENT OF METASTATIC BREAST CANCER (MBC) WITH VONORELBINE AND DOCETAXEL
    Savio, Giuseppina
    Leonardi, Vita
    Laudani, Agata
    Pepe, Alessio
    Calabria, Caterina
    Scianna, Caterina
    Palmisano, Valentina
    Agostara, Biagio
    ANNALS OF ONCOLOGY, 2004, 15 : 20 - 21
  • [6] Treatment of metastatic breast cancer (MBC) with Vinorelbine and Docetaxel
    Savio, Giuseppina
    Leonardi, Vita
    Alu, Massimiliano
    Laudani, Agata
    Calabria, Caterina
    Scianna, Caterina
    Agostara, Biagio
    Ascoli, Maurizio
    ANNALS OF ONCOLOGY, 2004, 15 : 48 - 48
  • [7] A pharmacokinetic (PK) study on capecitabine (CAPE) in elderly patients with metastatic breast (MBC) or colo-rectal cancer (CRC)
    Longobardi, C.
    Strocchi, E.
    Di Fabio, F.
    Pinto, C.
    Camaggi, C.M.
    Zoli, N.
    Funaioli, C.
    Mutri, V.
    Liimpe, FLR
    Martoni, A.A.
    ANNALS OF ONCOLOGY, 2006, 17 : XI33 - XI34
  • [8] Weekly application of docetaxel in patients with previously treated metastatic breast cancer (MBC).
    Krapfl-Gast, AS
    Grischke, EM
    Bastert, G
    ANNALS OF ONCOLOGY, 2000, 11 : 30 - 30
  • [9] Dose finding and pharmacokinetic (PK) study of daily oral idarubicin (IDA) in metastatic breast cancer (MBC)
    Sorio, R
    Toffoli, G
    Robieux, I
    Rimondi, G
    Aita, P
    Corona, G
    Crivellari, D
    Colussi, AM
    Tumolo, S
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1136 - 1136
  • [10] Gemcitabine and docetaxel combination regimen in metastatic breast cancer (MBC)
    Karacetin, D.
    Maral, O.
    Aksakal, O.
    Okten, B.
    Yalcin, B.
    Incekara, O.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345